9 May 2020 in Oxidative Medicine and Cellular Longevity
The global population above 60 years has been growing exponentially in the last decades, which is accompanied by an increase in the prevalence of age-related chronic diseases, highlighting cardiovascular diseases (CVDs), such as hypertension, atherosclerosis, and heart failure. Aging is the main risk factor for these diseases. Such susceptibility to disease is explained, at least in part, by the increase of oxidative stress, in which it damages cellular components such as proteins, DNA, and lipids. In addition, the chronic inflammatory process in aging “inflammaging” also contributes to cell damage, creating a stressful environment which drives to the development of CVDs. Taken together, it is possible to identify the molecular connection between oxidative stress and the inflammatory process, especially by the crosstalk between the transcription factors Nrf-2 and NF-κB which are mediated by redox signalling and are involved in aging. Therapies that control this process are key targets in the prevention/combat of age-related CVDs. In this review, we show the basics of inflammation and oxidative stress, including the crosstalk between them, and the implications on age-related CVDs.
15 April 2021 in PLOS ONE
MRMathania Silva de Almeida Rezende
Mathania Silva de Almeida Rezende
TGTays Amanda Felisberto Gonçalves
Tays Amanda Felisberto Gonçalves
FAFátima de Lourdes Assunção Araújo de Azevedo
Fátima de Lourdes Assunção Araújo de Azevedo
+7
Erectile dysfunction (ED) is defined as the inability to achieve and/or maintain penile erection sufficient for satisfactory sexual relations, and aging is one of the main risk factors involved. The D-(+)-Galactose aging model is a consolidated methodology for studies of cardiovascular aging; however, its potential for use with ED remain unexplored. The present study proposed to characterize a new experimental model for ED, using the D-(+)-Galactose aging model. For the experiments, the animals were randomly divided into three groups receiving: vehicle (CTL), D-galactose 150 mg/kg (DGAL), and D-(+)-galactose 150 mg/Kg + sildenafil 1.5 mg/Kg (DGAL+SD1.5) being administered daily for a period of eight weeks. All of the experimental protocols were previously approved by the Ethics Committee on the Use of Animals at the Federal University of Paraíba n° 9706070319. During the treatment, we analyzed physical, molecular, and physiological aspects related to the aging process and implicated in the development of ED. Our findings demonstrate for the first time that D-(+)-Galactose-induced aging represents a suitable experimental model for ED assessment. This was evidenced by an observed hyper-contractility in corpora cavernosa, significant endothelial dysfunction, increased ROS levels, an increase in cavernous tissue senescence, and the loss of essential penile erectile components.
1 August 2019 in Saúde (Santa Maria)
As doenças parasitárias causam sintomas que muitas vezes incapacitam o indivíduo na realização de suas atividades normais. Por isso este estudo objetiva avaliar o perfil socioeconômico e a qualidade de vida de pacientes com protozooses intestinais atendidos em um hospital universitário. Foi realizada uma pesquisa exploratória de natureza observacional transversal, através da aplicação do questionário de qualidade de vida SF-36, no laboratório de Análises Clínicas do Hospital Universitário Lauro Wanderley, entre Fevereiro e Agosto de 2017. Das 77 amostras analisadas, 27% foram positivas para protozoários, onde a espécie mais frequente foi Endolimax nana (52,38%), seguida por Entamoeba histolytica/dispar (23,82%) e Entamoeba coli (19,04%). A maioria dos entrevistados eram do sexo feminino (76%), com faixa etária maior que 30 anos (85,7%), ensino fundamental incompleto (38,1%) e renda familiar igual a um salário mínimo (81%). Quanto ao questionário de qualidade de vida SF-36, os domínios estado geral de saúde e dor apresentaram as menores médias: 50,19 e 59,14 respectivamente. Tem-se que a ocorrência de protozooses intestinais promovem impactos na qualidade de vida de indivíduos infectados, sendo necessário que haja investimentos em medidas de controle e prevenção das mesmas.